Old Web
English
Sign In
Acemap
>
authorDetail
>
Yingnan Yu
Yingnan Yu
Irinotecan
Medicine
Capecitabine
Dosing
Pathology
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oxaliplatin (OX), chronomodulated capecitabine, and UGT1A1 genotype-directed dosing of irinotecan (IR) triplet chemotherapy (OXIRI) in patients (pts) with advanced pancreatic cancer (APC).
2018
Journal of Clinical Oncology
Amanda Oon Lim Seet
Sylvia Chen
Yingnan Yu
Su Pin Choo
David Wai-Meng Tai
Justina Yick Ching Lam
Yvonne Chang
Balram Chowbay
Matthew Ch Ng
Show All
Source
Cite
Save
Citations (0)
Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review
2016
Drug Metabolism Reviews
Sylvia Chen
Natalia Sutiman
Clara Zhenxian Zhang
Yingnan Yu
Shirley Lam
Chiea Chuen Khor
Balram Chowbay
Show All
Source
Cite
Save
Citations (14)
1